Wheeler HR - Search Results

1

Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma-A Case Report and Systematic Review.

Yuile A, Satgunaseelan L, Wei J, Kastelan M, Back MF, Lee M, Wei H, Buckland ME, Lee A, Wheeler HR. Yuile A, et al. Among authors: wheeler hr. Curr Issues Mol Biol. 2022 Oct 21;44(10):5117-5125. doi: 10.3390/cimb44100348. Curr Issues Mol Biol. 2022. PMID: 36286062 Free PMC article.

2

The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years' experience at a single centre.

Parkinson JF, Afaghi V, Payne CA, Buckland ME, Brewer JM, Biggs MT, Little NS, Wheeler HR, Cook RJ, McDonald KL. Parkinson JF, et al. Among authors: wheeler hr. J Clin Neurosci. 2011 Mar;18(3):329-33. doi: 10.1016/j.jocn.2010.07.101. Epub 2011 Jan 17. J Clin Neurosci. 2011. PMID: 21247767

3

Expanding the spectrum of IDH1 mutations in gliomas.

Gupta R, Flanagan S, Li CC, Lee M, Shivalingham B, Maleki S, Wheeler HR, Buckland ME. Gupta R, et al. Among authors: wheeler hr. Mod Pathol. 2013 May;26(5):619-25. doi: 10.1038/modpathol.2012.210. Epub 2013 Jan 11. Mod Pathol. 2013. PMID: 23307057 Free article.

4

Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M. Gzell C, et al. J Cancer Surviv. 2014 Mar;8(1):108-13. doi: 10.1007/s11764-013-0311-9. Epub 2013 Nov 9. J Cancer Surviv. 2014. PMID: 24214496

5

Correlation of MicroRNA 132 Up-regulation with an Unfavorable Clinical Outcome in Patients with Primary Glioblastoma Multiforme Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide Chemotherapy.

Parker NR, Correia N, Crossley B, Buckland ME, Howell VM, Wheeler HR. Parker NR, et al. Among authors: wheeler hr. Transl Oncol. 2013 Dec 1;6(6):742-8. doi: 10.1593/tlo.13553. eCollection 2013 Dec 1. Transl Oncol. 2013. PMID: 24466377 Free PMC article.

6

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network; Erber WN, McDonald KL. Tabone T, et al. J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2. J Clin Pathol. 2014. PMID: 24695838

7

Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M. Gzell C, et al. J Neurooncol. 2014 Aug;119(1):187-96. doi: 10.1007/s11060-014-1472-8. Epub 2014 May 15. J Neurooncol. 2014. PMID: 24830984

8

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Back M, Gzell CE, Kastelan M, Guo L, Wheeler HR. Back M, et al. Among authors: wheeler hr. Neurooncol Pract. 2015 Mar;2(1):48-53. doi: 10.1093/nop/npu031. Epub 2014 Dec 15. Neurooncol Pract. 2015. PMID: 26034641 Free PMC article.

9

Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma.

Gzell C, Wheeler H, Huang D, Gaur P, Chen J, Kastelan M, Back M. Gzell C, et al. Clin Oncol (R Coll Radiol). 2016 Mar;28(3):215-22. doi: 10.1016/j.clon.2015.08.009. Epub 2015 Sep 14. Clin Oncol (R Coll Radiol). 2016. PMID: 26382848

10

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Gzell CE, Wheeler HR, McCloud P, Kastelan M, Back M. Gzell CE, et al. Among authors: wheeler hr. J Neurooncol. 2016 May;128(1):67-74. doi: 10.1007/s11060-016-2074-4. Epub 2016 Feb 15. J Neurooncol. 2016. PMID: 26879084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page